Skip to main content
Updating results


  • Updated

LONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.

Get up-to-the-minute news sent straight to your device.


News Alerts

Breaking News